Treatment.Com International Inc. (TRUE.CN)

CAD 0.41

(-1.22%)

Operating Expenses Summary of Treatment.Com International Inc.

Treatment.Com International Inc.'s latest annual operating expenses in 2023 was 2.32 Million CAD , down -38.56% from previous year.
Treatment.Com International Inc.'s latest quarterly operating expenses in 2024 Q2 was 1.72 Million CAD , up 92.25% from previous quarter.
Treatment.Com International Inc. reported a annual operating expenses of 3.78 Million CAD in annual operating expenses 2022, down -72.75% from previous year.
Treatment.Com International Inc. reported a annual operating expenses of 13.89 Million CAD in annual operating expenses 2021, up 377.84% from previous year.
Treatment.Com International Inc. reported a quarterly operating expenses of 904.02 Thousand CAD for 2024 Q1, up 11.13% from previous quarter.
Treatment.Com International Inc. reported a quarterly operating expenses of 269.12 Thousand CAD for 2023 Q2, down -25.78% from previous quarter.

Annual Operating Expenses Chart of Treatment.Com International Inc. (2023 - 2017)

Historical Annual Operating Expenses of Treatment.Com International Inc. (2023 - 2017)

Year	Operating Expenses	Operating Expenses Growth
2023	2.32 Million CAD	-38.56%
2022	3.78 Million CAD	-72.75%
2021	13.89 Million CAD	377.84%
2020	2.9 Million CAD	332.54%
2019	672.36 Thousand CAD	859.37%
2018	70.08 Thousand CAD	-27.39%
2017	96.51 Thousand CAD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	1.72 Million CAD	92.25%
2024 Q1	904.02 Thousand CAD	11.13%
2023 Q2	269.12 Thousand CAD	-25.78%
2023 Q4	813.5 Thousand CAD	-7.73%
2023 Q3	881.7 Thousand CAD	227.61%
2023 FY	2.32 Million CAD	-38.56%
2023 Q1	362.6 Thousand CAD	-56.1%
2022 Q4	825.96 Thousand CAD	136.6%
2022 Q3	349.09 Thousand CAD	-41.6%
2022 Q2	597.79 Thousand CAD	-70.32%
2022 FY	3.78 Million CAD	-72.75%
2022 Q1	2.01 Million CAD	-65.98%
2021 Q4	5.92 Million CAD	27.47%
2021 FY	13.89 Million CAD	377.84%
2021 Q3	4.64 Million CAD	106.14%
2021 Q2	2.25 Million CAD	109.4%
2021 Q1	1.07 Million CAD	-15.62%
2020 Q4	1.27 Million CAD	101.1%
2020 FY	2.9 Million CAD	332.54%
2020 Q3	634.21 Thousand CAD	-15.73%
2020 Q2	752.61 Thousand CAD	205.88%
2020 Q1	246.04 Thousand CAD	-91.25%
2019 Q4	2.81 Million CAD	6638.47%
2019 FY	672.36 Thousand CAD	859.37%
2019 Q3	41.71 Thousand CAD	0.0%
2018 FY	70.08 Thousand CAD	-27.39%
2017 FY	96.51 Thousand CAD	0.0%

Peer Operating Expenses Comparison of Treatment.Com International Inc.

Name	Operating Expenses	Operating Expenses Difference
AI/ML Innovations Inc.	1.95 Million CAD	-18.736%
Diagnamed Holdings Corp.	1.17 Million CAD	-97.589%
Pangenomic Health Inc.	2.03 Million CAD	-14.608%
nDatalyze Corp.	381.76 Thousand CAD	-509.526%
Unidoc Health Corp.	2.13 Million CAD	-9.124%